Contact Information: For further information contact: David Carey Lazar Partners Ltd. 212-867-1768
Electro-Optical Sciences Joins Russell Microcap Index
| Source: Electro-Optical Sciences
IRVINGTON, NY--(Marketwire - July 1, 2008) - Electro-Optical Sciences, Inc. ("EOS")
(NASDAQ : MELA ), a medical device company focused on the design and
development of MelaFind®, a non-invasive, point-of-care instrument to
assist in the early diagnosis of melanoma, announced today that the company
has joined the Russell Mircocap Index based on a preliminary list of
additions posted June 27, 2008 on www.russell.com.
Membership in the Russell Microcap Index, which remains in place for one
year, means automatic inclusion in the appropriate growth and value style
indexes. Russell determines membership for its equity indexes primarily by
objective, market-capitalization rankings and style attributes.
Russell indexes are widely used by investment managers and institutional
investors for index funds and as benchmarks for both passive and active
investment strategies. An industry-leading $4.4 trillion in assets
currently are benchmarked to them.
About Electro-Optical Sciences
EOS is a medical device company focused on designing and developing a
non-invasive, point-of-care instrument to assist in the early diagnosis of
melanoma. MelaFind features a hand-held imaging device that emits light of
multiple wavelengths to capture images of suspicious pigmented skin lesions
and extract data. Using sophisticated algorithms, the data are then
analyzed against a proprietary database of melanomas and benign lesions in
order to provide information to the physician and produce a recommendation
of whether the lesion should be biopsied.
Melanoma is the deadliest of skin cancers, responsible for approximately
80% of all skin cancer deaths. Unless melanoma is detected early and
excised with proper margins, the patient survival rate is poor, as there is
currently no cure for advanced stage melanoma.
For more information on EOS, visit www.eosciences.com.
About Russell
Russell Investments aims to improve financial security for people by
providing strategic advice, world-class implementation, state-of-the-art
performance benchmarks, and a range of institutional-quality investment
products. With more than $213 billion in assets under management, Russell
serves individual, institutional and advisor clients in more than 40
countries. Russell provides access to some of the world's best money
managers. It helps investors put this access to work in corporate defined
benefit and defined contribution plans, and in the life savings of
individual investors.
Founded in 1936, Russell is a subsidiary of Northwestern Mutual Life
Insurance Company. Headquartered in Tacoma, Wash., U.S., Russell has
principal offices in Amsterdam, Auckland, Johannesburg, London, Melbourne,
New York, Paris, San Francisco, Singapore, Sydney, Tokyo and Toronto.
Safe Harbor
This press release includes "forward-looking statements" within the meaning
of the Securities Litigation Reform Act of 1995. These statements include
but are not limited to our plans, objectives, expectations and intentions
and other statements that contain words such as "expects," "contemplates,"
"anticipates," "plans," "intends," "believes" and variations of such words
or similar expressions that predict or indicate future events or trends, or
that do not relate to historical matters. These statements are based on our
current beliefs or expectations and are inherently subject to significant
uncertainties and changes in circumstances, many of which are beyond our
control. There can be no assurance that our beliefs or expectations will be
achieved. Actual results may differ materially from our beliefs or
expectations due to economic, business, competitive, market and regulatory
factors.